annual D&A:
$69.54M-$42.23M(-37.79%)Summary
- As of today (August 16, 2025), GDRX annual depreciation & amortization is $69.54 million, with the most recent change of -$42.23 million (-37.79%) on December 31, 2024.
- During the last 3 years, GDRX annual D&A has risen by +$31.90 million (+84.74%).
- GDRX annual D&A is now -37.79% below its all-time high of $111.77 million, reached on December 31, 2023.
Performance
GDRX Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$19.73M-$1.18M(-5.66%)Summary
- As of today (August 16, 2025), GDRX quarterly depreciation & amortization is $19.73 million, with the most recent change of -$1.18 million (-5.66%) on June 30, 2025.
- Over the past year, GDRX quarterly D&A has increased by +$2.76 million (+16.29%).
- GDRX quarterly D&A is now -54.76% below its all-time high of $43.61 million, reached on December 31, 2023.
Performance
GDRX quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$77.27M+$2.76M(+3.71%)Summary
- As of today (August 16, 2025), GDRX TTM depreciation & amortization is $77.27 million, with the most recent change of +$2.76 million (+3.71%) on June 30, 2025.
- Over the past year, GDRX TTM D&A has dropped by -$32.27 million (-29.46%).
- GDRX TTM D&A is now -29.46% below its all-time high of $109.54 million, reached on June 30, 2024.
Performance
GDRX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
GDRX Depreciation and amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -37.8% | +16.3% | -29.5% |
3 y3 years | +84.7% | +48.1% | +69.8% |
5 y5 years | +342.3% | +336.4% | +771.5% |
GDRX Depreciation and amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -37.8% | +84.7% | -54.8% | +48.1% | -29.5% | +69.8% |
5 y | 5-year | -37.8% | +342.3% | -54.8% | +348.0% | -29.5% | +771.5% |
alltime | all time | -37.8% | +609.1% | -54.8% | +354.1% | -29.5% | +1678.4% |
GDRX Depreciation and amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $19.73M(-5.7%) | $77.27M(+3.7%) |
Mar 2025 | - | $20.91M(+9.5%) | $74.51M(+7.1%) |
Dec 2024 | $69.54M(-37.8%) | $19.10M(+8.9%) | $69.54M(-26.1%) |
Sep 2024 | - | $17.54M(+3.4%) | $94.05M(-14.1%) |
Jun 2024 | - | $16.96M(+6.4%) | $109.54M(+0.8%) |
Mar 2024 | - | $15.94M(-63.4%) | $108.67M(+0.9%) |
Dec 2023 | $111.77M(+94.3%) | $43.61M(+32.0%) | $107.67M(+35.3%) |
Sep 2023 | - | $33.02M(+105.2%) | $79.59M(+31.5%) |
Jun 2023 | - | $16.10M(+7.8%) | $60.52M(+4.8%) |
Mar 2023 | - | $14.94M(-3.8%) | $57.74M(+6.6%) |
Dec 2022 | $57.53M | $15.53M(+11.3%) | $54.18M(+9.9%) |
Sep 2022 | - | $13.95M(+4.8%) | $49.29M(+8.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2022 | - | $13.32M(+17.1%) | $45.50M(+12.2%) |
Mar 2022 | - | $11.37M(+6.8%) | $40.55M(+17.4%) |
Dec 2021 | $37.64M(+64.3%) | $10.65M(+4.8%) | $34.54M(+22.1%) |
Sep 2021 | - | $10.16M(+21.4%) | $28.30M(+21.5%) |
Jun 2021 | - | $8.37M(+56.1%) | $23.29M(+19.8%) |
Mar 2021 | - | $5.36M(+21.7%) | $19.45M(+5.5%) |
Dec 2020 | $22.91M(+45.7%) | $4.40M(-14.7%) | $18.43M(+31.4%) |
Sep 2020 | - | $5.16M(+14.1%) | $14.03M(+58.2%) |
Jun 2020 | - | $4.52M(+4.1%) | $8.87M(+104.1%) |
Mar 2020 | - | $4.34M | $4.34M |
Dec 2019 | $15.72M(+60.3%) | - | - |
Dec 2018 | $9.81M | - | - |
FAQ
- What is GoodRx Holdings, Inc. annual depreciation & amortization?
- What is the all time high annual D&A for GoodRx Holdings, Inc.?
- What is GoodRx Holdings, Inc. annual D&A year-on-year change?
- What is GoodRx Holdings, Inc. quarterly depreciation & amortization?
- What is the all time high quarterly D&A for GoodRx Holdings, Inc.?
- What is GoodRx Holdings, Inc. quarterly D&A year-on-year change?
- What is GoodRx Holdings, Inc. TTM depreciation & amortization?
- What is the all time high TTM D&A for GoodRx Holdings, Inc.?
- What is GoodRx Holdings, Inc. TTM D&A year-on-year change?
What is GoodRx Holdings, Inc. annual depreciation & amortization?
The current annual D&A of GDRX is $69.54M
What is the all time high annual D&A for GoodRx Holdings, Inc.?
GoodRx Holdings, Inc. all-time high annual depreciation & amortization is $111.77M
What is GoodRx Holdings, Inc. annual D&A year-on-year change?
Over the past year, GDRX annual depreciation & amortization has changed by -$42.23M (-37.79%)
What is GoodRx Holdings, Inc. quarterly depreciation & amortization?
The current quarterly D&A of GDRX is $19.73M
What is the all time high quarterly D&A for GoodRx Holdings, Inc.?
GoodRx Holdings, Inc. all-time high quarterly depreciation & amortization is $43.61M
What is GoodRx Holdings, Inc. quarterly D&A year-on-year change?
Over the past year, GDRX quarterly depreciation & amortization has changed by +$2.76M (+16.29%)
What is GoodRx Holdings, Inc. TTM depreciation & amortization?
The current TTM D&A of GDRX is $77.27M
What is the all time high TTM D&A for GoodRx Holdings, Inc.?
GoodRx Holdings, Inc. all-time high TTM depreciation & amortization is $109.54M
What is GoodRx Holdings, Inc. TTM D&A year-on-year change?
Over the past year, GDRX TTM depreciation & amortization has changed by -$32.27M (-29.46%)